U.S. FDA Requirements: Cilastatin Sodium; Imipenem
In the United States, Cilastatin Sodium; Imipenem is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Cilastatin Sodium; Imipenem.
For more information about Cilastatin Sodium; Imipenem, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.